These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38085056)
21. Genetic variation associated with childhood and adult stature and risk of MYCN-amplified neuroblastoma. Semmes EC; Shen E; Cohen JL; Zhang C; Wei Q; Hurst JH; Walsh KM Cancer Med; 2020 Nov; 9(21):8216-8225. PubMed ID: 32945147 [TBL] [Abstract][Full Text] [Related]
22. MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2. Ding Y; Yang J; Ma Y; Yao T; Chen X; Ge S; Wang L; Fan X J Exp Clin Cancer Res; 2019 Dec; 38(1):498. PubMed ID: 31856871 [TBL] [Abstract][Full Text] [Related]
23. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma. Lee E; Lee JW; Lee B; Park K; Shim J; Yoo KH; Koo HH; Sung KW; Park WY BMC Med Genomics; 2020 Nov; 13(1):171. PubMed ID: 33172452 [TBL] [Abstract][Full Text] [Related]
24. Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma. Tee AE; Ciampa OC; Wong M; Fletcher JI; Kamili A; Chen J; Ho N; Sun Y; Carter DR; Cheung BB; Marshall GM; Liu PY; Liu T Int J Cancer; 2020 Oct; 147(7):1928-1938. PubMed ID: 32086952 [TBL] [Abstract][Full Text] [Related]
26. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme. Eller JL; Longo SL; Hicklin DJ; Canute GW Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411 [TBL] [Abstract][Full Text] [Related]
27. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells. O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962 [TBL] [Abstract][Full Text] [Related]
28. Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma. Wang H; Wang X; Xu L; Zhang J; Cao H BMC Pediatr; 2021 Jun; 21(1):272. PubMed ID: 34116676 [TBL] [Abstract][Full Text] [Related]
29. Venetoclax-based Rational Combinations are Effective in Models of Dalton KM; Krytska K; Lochmann TL; Sano R; Casey C; D'Aulerio A; Khan QA; Crowther GS; Coon C; Cai J; Jacob S; Kurupi R; Hu B; Dozmorov M; Greninger P; Souers AJ; Benes CH; Mossé YP; Faber AC Mol Cancer Ther; 2021 Aug; 20(8):1400-1411. PubMed ID: 34088831 [TBL] [Abstract][Full Text] [Related]
30. Prominent Staining of MYCN Immunohistochemistry Predicts a Poor Prognosis in Zhao M; Gu W; Liu F; Yu L; Shu Y; Liu L; Hu J; Liu Y; Tang H; Mao J Pediatr Dev Pathol; 2023; 26(2):124-132. PubMed ID: 36775958 [TBL] [Abstract][Full Text] [Related]